These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
93 related items for PubMed ID: 9677474
1. p53 germline polymorphisms are associated with an increased risk for breast cancer in German women. Wang-Gohrke S, Rebbeck TR, Besenfelder W, Kreienberg R, Runnebaum IB. Anticancer Res; 1998; 18(3B):2095-9. PubMed ID: 9677474 [Abstract] [Full Text] [Related]
2. p53 genotypes and haplotypes associated with risk of breast cancer. Buyru N, Altinisik J, Demokan S, Dalay N. Cancer Detect Prev; 2007; 31(3):207-13. PubMed ID: 17574348 [Abstract] [Full Text] [Related]
10. Polymorphisms in three base excision repair genes and breast cancer risk in Thai women. Sangrajrang S, Schmezer P, Burkholder I, Waas P, Boffetta P, Brennan P, Bartsch H, Wiangnon S, Popanda O. Breast Cancer Res Treat; 2008 Sep; 111(2):279-88. PubMed ID: 17922186 [Abstract] [Full Text] [Related]
12. HER-2 [Ile655Val] polymorphism in association with breast cancer risk: a population-based case-control study in Slovakia. Zúbor P, Vojvodová A, Danko J, Kajo K, Szunyogh N, Lasabová Z, Biringer K, Visnovský J, Dókus K, Galajda P, Plank L. Neoplasma; 2006 Sep; 53(1):49-55. PubMed ID: 16416013 [Abstract] [Full Text] [Related]
13. Clarifying the PROGINS allele association in ovarian and breast cancer risk: a haplotype-based analysis. Pearce CL, Hirschhorn JN, Wu AH, Burtt NP, Stram DO, Young S, Kolonel LN, Henderson BE, Altshuler D, Pike MC. J Natl Cancer Inst; 2005 Jan 05; 97(1):51-9. PubMed ID: 15632380 [Abstract] [Full Text] [Related]
14. Polymorphisms of HER2 Ile655Val and cyclin D1 (CCND1) G870A are not associated with breast cancer risk but polymorphic allele of HER2 is associated with nodal metastases. Naidu R, Yip CH, Taib NA. Neoplasma; 2008 Jan 05; 55(2):87-95. PubMed ID: 18237245 [Abstract] [Full Text] [Related]
15. Two functionally relevant polymorphisms in the human progesterone receptor gene (+331 G/A and progins) and the predisposition for breast and/or ovarian cancer. Romano A, Lindsey PJ, Fischer DC, Delvoux B, Paulussen AD, Janssen RG, Kieback DG. Gynecol Oncol; 2006 May 05; 101(2):287-95. PubMed ID: 16360811 [Abstract] [Full Text] [Related]
17. ERCC2 genotypes and a corresponding haplotype are linked with breast cancer risk in a German population. Justenhoven C, Hamann U, Pesch B, Harth V, Rabstein S, Baisch C, Vollmert C, Illig T, Ko YD, Brüning T, Brauch H. Cancer Epidemiol Biomarkers Prev; 2004 Dec 05; 13(12):2059-64. PubMed ID: 15598761 [Abstract] [Full Text] [Related]
18. XRCC1 and XPD genetic polymorphisms, smoking and breast cancer risk in a Finnish case-control study. Metsola K, Kataja V, Sillanpää P, Siivola P, Heikinheimo L, Eskelinen M, Kosma VM, Uusitupa M, Hirvonen A. Breast Cancer Res; 2005 Dec 05; 7(6):R987-97. PubMed ID: 16280050 [Abstract] [Full Text] [Related]
19. Association of p53 genetic polymorphism (Arg72Pro) with estrogen receptor positive breast cancer risk in Japanese women. Noma C, Miyoshi Y, Taguchi T, Tamaki Y, Noguchi S. Cancer Lett; 2004 Jul 16; 210(2):197-203. PubMed ID: 15183535 [Abstract] [Full Text] [Related]
20. A study on the association of cytochrome-P450 1A1 polymorphism and breast cancer risk in north Indian women. Singh V, Rastogi N, Sinha A, Kumar A, Mathur N, Singh MP. Breast Cancer Res Treat; 2007 Jan 16; 101(1):73-81. PubMed ID: 16807674 [Abstract] [Full Text] [Related] Page: [Next] [New Search]